• info@reportsandmarkets.com
  • +44-020-3286-9338 (UK) +1-214-377-1121 (US)
  • Sign In
  • Register

OtherGlobal Oncolytic Virus Immunotherapy Market 2018 by Manufacturers, Countries, Type and Application, Forecast to 2023

  • RnM2414326
  • |
  • 14 September, 2018
  • |
  • Global
  • |
  • 123 pages
  • |
  • GIR (Global Info Research)
  • |
  • Other

Oncology Immunotherapy exploits virus's ability to replicate selectively and kill tumor tissue while at the same time regulate the specific immune response of a patient The first oncolytic virus to demonstrate a clinical benefit in patients with melanoma is genetically modified herpes simplex virus type I i.e. Talimogene laherparepvec (T-VEC).

Scope of the Report:

This report studies the Oncolytic Virus Immunotherapy market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and splits the Oncolytic Virus Immunotherapy market by product type and applications/end industries.

North America is leading in the oncolytic virus immunotherapy market globally, according to Skin Cancer Foundation Statistics, Globally 132,000 melanoma skin cancers occur each year. One in every three cancers diagnosed is a skin cancer, and one in every five Americans will develop skin cancer in their lifetime. North America has well-developed healthcare infrastructure with massive investment in research and development of oncolytic virus immunotherapy.

The global Oncolytic Virus Immunotherapy market is valued at xx million USD in 2017 and is expected to reach xx million USD by the end of 2023, growing at a CAGR of xx% between 2017 and 2023.

The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.

North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of Oncolytic Virus Immunotherapy.

Europe also play important roles in global market, with market size of xx million USD in 2017 and will be xx million USD in 2023, with a CAGR of xx%.

Market Segment by Companies, this report covers

Merck

Amgen

TILT Biotherapeutics

Oncorus

Sorrento Therapeutics

Shanghai Sunway Biotech

Market Segment by Regions, regional analysis covers

North America (United States, Canada and Mexico)

Europe (Germany, France, UK, Russia and Italy)

Asia-Pacific (China, Japan, Korea, India and Southeast Asia)

South America (Brazil, Argentina, Colombia)

Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers

Engineering Oncolytic Viruses

Wild-Type Oncolytic Viruses

Market Segment by Applications, can be divided into

Hospitals

Clinics

Ambulatory Surgical Centers


Table of Contents

1 Oncolytic Virus Immunotherapy Market Overview

1.1 Product Overview and Scope of Oncolytic Virus Immunotherapy

1.2 Classification of Oncolytic Virus Immunotherapy by Types

1.2.1 Global Oncolytic Virus Immunotherapy Revenue Comparison by Types (2017-2023)

1.2.2 Global Oncolytic Virus Immunotherapy Revenue Market Share by Types in 2017

1.2.3 Engineering Oncolytic Viruses

1.2.4 Wild-Type Oncolytic Viruses

1.3 Global Oncolytic Virus Immunotherapy Market by Application

1.3.1 Global Oncolytic Virus Immunotherapy Market Size and Market Share Comparison by Applications (2013-2023)

1.3.2 Hospitals

1.3.3 Clinics

1.3.4 Ambulatory Surgical Centers

1.4 Global Oncolytic Virus Immunotherapy Market by Regions

1.4.1 Global Oncolytic Virus Immunotherapy Market Size (Million USD) Comparison by Regions (2013-2023)

1.4.1 North America (USA, Canada and Mexico) Oncolytic Virus Immunotherapy Status and Prospect (2013-2023)

1.4.2 Europe (Germany, France, UK, Russia and Italy) Oncolytic Virus Immunotherapy Status and Prospect (2013-2023)

1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Oncolytic Virus Immunotherapy Status and Prospect (2013-2023)

1.4.4 South America (Brazil, Argentina, Colombia) Oncolytic Virus Immunotherapy Status and Prospect (2013-2023)

1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Oncolytic Virus Immunotherapy Status and Prospect (2013-2023)

1.5 Global Market Size of Oncolytic Virus Immunotherapy (2013-2023)

2 Manufacturers Profiles

2.1 Merck

2.1.1 Business Overview

2.1.2 Oncolytic Virus Immunotherapy Type and Applications

2.1.2.1 Product A

2.1.2.2 Product B

2.1.3 Merck Oncolytic Virus Immunotherapy Revenue, Gross Margin and Market Share (2016-2017)

2.2 Amgen

2.2.1 Business Overview

2.2.2 Oncolytic Virus Immunotherapy Type and Applications

2.2.2.1 Product A

2.2.2.2 Product B

2.2.3 Amgen Oncolytic Virus Immunotherapy Revenue, Gross Margin and Market Share (2016-2017)

2.3 TILT Biotherapeutics

2.3.1 Business Overview

2.3.2 Oncolytic Virus Immunotherapy Type and Applications

2.3.2.1 Product A

2.3.2.2 Product B

2.3.3 TILT Biotherapeutics Oncolytic Virus Immunotherapy Revenue, Gross Margin and Market Share (2016-2017)

2.4 Oncorus

2.4.1 Business Overview

2.4.2 Oncolytic Virus Immunotherapy Type and Applications

2.4.2.1 Product A

2.4.2.2 Product B

2.4.3 Oncorus Oncolytic Virus Immunotherapy Revenue, Gross Margin and Market Share (2016-2017)

2.5 Sorrento Therapeutics

2.5.1 Business Overview

2.5.2 Oncolytic Virus Immunotherapy Type and Applications

2.5.2.1 Product A

2.5.2.2 Product B

2.5.3 Sorrento Therapeutics Oncolytic Virus Immunotherapy Revenue, Gross Margin and Market Share (2016-2017)

2.6 Shanghai Sunway Biotech

2.6.1 Business Overview

2.6.2 Oncolytic Virus Immunotherapy Type and Applications

2.6.2.1 Product A

2.6.2.2 Product B

2.6.3 Shanghai Sunway Biotech Oncolytic Virus Immunotherapy Revenue, Gross Margin and Market Share (2016-2017)

3 Global Oncolytic Virus Immunotherapy Market Competition, by Players

3.1 Global Oncolytic Virus Immunotherapy Revenue and Share by Players (2013-2018)

3.2 Market Concentration Rate

3.2.1 Top 5 Oncolytic Virus Immunotherapy Players Market Share

3.2.2 Top 10 Oncolytic Virus Immunotherapy Players Market Share

3.3 Market Competition Trend

4 Global Oncolytic Virus Immunotherapy Market Size by Regions

4.1 Global Oncolytic Virus Immunotherapy Revenue and Market Share by Regions

4.2 North America Oncolytic Virus Immunotherapy Revenue and Growth Rate (2013-2018)

4.3 Europe Oncolytic Virus Immunotherapy Revenue and Growth Rate (2013-2018)

4.4 Asia-Pacific Oncolytic Virus Immunotherapy Revenue and Growth Rate (2013-2018)

4.5 South America Oncolytic Virus Immunotherapy Revenue and Growth Rate (2013-2018)

4.6 Middle East and Africa Oncolytic Virus Immunotherapy Revenue and Growth Rate (2013-2018)

5 North America Oncolytic Virus Immunotherapy Revenue by Countries

5.1 North America Oncolytic Virus Immunotherapy Revenue by Countries (2013-2018)

5.2 USA Oncolytic Virus Immunotherapy Revenue and Growth Rate (2013-2018)

5.3 Canada Oncolytic Virus Immunotherapy Revenue and Growth Rate (2013-2018)

5.4 Mexico Oncolytic Virus Immunotherapy Revenue and Growth Rate (2013-2018)

6 Europe Oncolytic Virus Immunotherapy Revenue by Countries

6.1 Europe Oncolytic Virus Immunotherapy Revenue by Countries (2013-2018)

6.2 Germany Oncolytic Virus Immunotherapy Revenue and Growth Rate (2013-2018)

6.3 UK Oncolytic Virus Immunotherapy Revenue and Growth Rate (2013-2018)

6.4 France Oncolytic Virus Immunotherapy Revenue and Growth Rate (2013-2018)

6.5 Russia Oncolytic Virus Immunotherapy Revenue and Growth Rate (2013-2018)

6.6 Italy Oncolytic Virus Immunotherapy Revenue and Growth Rate (2013-2018)

7 Asia-Pacific Oncolytic Virus Immunotherapy Revenue by Countries

7.1 Asia-Pacific Oncolytic Virus Immunotherapy Revenue by Countries (2013-2018)

7.2 China Oncolytic Virus Immunotherapy Revenue and Growth Rate (2013-2018)

7.3 Japan Oncolytic Virus Immunotherapy Revenue and Growth Rate (2013-2018)

7.4 Korea Oncolytic Virus Immunotherapy Revenue and Growth Rate (2013-2018)

7.5 India Oncolytic Virus Immunotherapy Revenue and Growth Rate (2013-2018)

7.6 Southeast Asia Oncolytic Virus Immunotherapy Revenue and Growth Rate (2013-2018)

8 South America Oncolytic Virus Immunotherapy Revenue by Countries

8.1 South America Oncolytic Virus Immunotherapy Revenue by Countries (2013-2018)

8.2 Brazil Oncolytic Virus Immunotherapy Revenue and Growth Rate (2013-2018)

8.3 Argentina Oncolytic Virus Immunotherapy Revenue and Growth Rate (2013-2018)

8.4 Colombia Oncolytic Virus Immunotherapy Revenue and Growth Rate (2013-2018)

9 Middle East and Africa Revenue Oncolytic Virus Immunotherapy by Countries

9.1 Middle East and Africa Oncolytic Virus Immunotherapy Revenue by Countries (2013-2018)

9.2 Saudi Arabia Oncolytic Virus Immunotherapy Revenue and Growth Rate (2013-2018)

9.3 UAE Oncolytic Virus Immunotherapy Revenue and Growth Rate (2013-2018)

9.4 Egypt Oncolytic Virus Immunotherapy Revenue and Growth Rate (2013-2018)

9.5 Nigeria Oncolytic Virus Immunotherapy Revenue and Growth Rate (2013-2018)

9.6 South Africa Oncolytic Virus Immunotherapy Revenue and Growth Rate (2013-2018)

10 Global Oncolytic Virus Immunotherapy Market Segment by Type

10.1 Global Oncolytic Virus Immunotherapy Revenue and Market Share by Type (2013-2018)

10.2 Global Oncolytic Virus Immunotherapy Market Forecast by Type (2018-2023)

10.3 Engineering Oncolytic Viruses Revenue Growth Rate (2013-2023)

10.4 Wild-Type Oncolytic Viruses Revenue Growth Rate (2013-2023)

11 Global Oncolytic Virus Immunotherapy Market Segment by Application

11.1 Global Oncolytic Virus Immunotherapy Revenue Market Share by Application (2013-2018)

11.2 Oncolytic Virus Immunotherapy Market Forecast by Application (2018-2023)

11.3 Hospitals Revenue Growth (2013-2018)

11.4 Clinics Revenue Growth (2013-2018)

11.5 Ambulatory Surgical Centers Revenue Growth (2013-2018)

12 Global Oncolytic Virus Immunotherapy Market Size Forecast (2018-2023)

12.1 Global Oncolytic Virus Immunotherapy Market Size Forecast (2018-2023)

12.2 Global Oncolytic Virus Immunotherapy Market Forecast by Regions (2018-2023)

12.3 North America Oncolytic Virus Immunotherapy Revenue Market Forecast (2018-2023)

12.4 Europe Oncolytic Virus Immunotherapy Revenue Market Forecast (2018-2023)

12.5 Asia-Pacific Oncolytic Virus Immunotherapy Revenue Market Forecast (2018-2023)

12.6 South America Oncolytic Virus Immunotherapy Revenue Market Forecast (2018-2023)

12.7 Middle East and Africa Oncolytic Virus Immunotherapy Revenue Market Forecast (2018-2023)

13 Research Findings and Conclusion

14 Appendix

14.1 Methodology

14.2 Data Source


captcha
Enter the code in the box:


captcha
Enter the code in the box:

Single User License (PDF)

  • This license allows for use of a publication by one person.
  • This person may not print out a single copy of the publication.
  • This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
  • This person cannot share the publication (or any information contained therein) with any other person or persons.
  • Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
  • Customers who infringe these license terms are liable for a Global license fee.

 

Site License (PDF)*

  • This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
  • These users may print out a single copy of the publication.
  • These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
  • These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
  • Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
  • Customers who infringe these license terms are liable for a Global license fee.

 

Global License (PDF)*

  • This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
  • Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
  • These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.


captcha
Enter the code in the box:



Summary:
Get latest Market Research Reports on Oncolytic Virus Immunotherapy . Industry analysis & Market Report on Oncolytic Virus Immunotherapy is a syndicated market report, published as Global Oncolytic Virus Immunotherapy Market 2018 by Manufacturers, Countries, Type and Application, Forecast to 2023. It is complete Research Study and Industry Analysis of Oncolytic Virus Immunotherapy market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.


REPORT YOU MIGHT BE INTERESTED

Purchase this Report

$3,480.00
$5,220.00
$6,960.00
2,336.82
3,505.23
4,673.64
3,202.30
4,803.44
6,404.59
421,567.20
632,350.80
843,134.40
230,770.63
346,155.95
461,541.26
Add To Cart Credit card Logo

Related Reports


Reason to Buy